Kei Kishimoto

Chief Scientific Officer • Selecta Bio

Dr. Kishimoto is the Chief Scientific Officer of Selecta Biosciences, a biotechnology company developing synthetic
vaccines based on a novel self-assembling nanoparticle technology. Prior to joining Selecta, Dr. Kishimoto was Vice
President of Research at Momenta Pharmaceuticals where he led multidisciplinary teams in inflammation,
oncology, and cardiovascular disease. Previously he was Senior Director of Inflammation Research at Millennium
Pharmaceuticals, where he provided the scientific leadership for four programs in clinical development, and an
Associate Director of Immunology at Boehringer Ingelheim. Dr. Kishimoto received his doctoral degree in
Immunology from Harvard University and his post-doctoral training at Stanford University.

Also Speaking

Tony Ward

Chief Technology Officer • GPB Scientific, LLC

Becky Cap

Chief Operating Officer, GenCure, Senior Vice President • BioBridge Global

Ivan Wall

Director, Advanced Therapies Manufacturing National Training Centre and Co-Founder & Director of FourPlus Immersive • FourPlus Immersive

Event Info


Fun Run